Pharmacy and drug development
- Professor, Department of Medicinal Chemistry, College of Pharmacy
- Director, Graduate Studies
David M. Ferguson, PhD, is a medicinal chemist and creator of the University of Minnesota College of Pharmacy's popular Drugs of Abuse class. His research interests include opioids, anticancer agents, computational chemistry and structure based drug design. His lab is currently applying synthetic medicinal chemistry to anticancer drug research.
- Professor and Head, Department of Medicinal Chemistry, College of Pharmacy
- Director, Institute for Therapeutics Discovery and Development
Gunda Georg, PhD, professor and head of the Department of Medicinal Chemistry in the College of Pharmacy, and her lab are currently investigating therapies for cancer, male and female birth control, epilepsy and Alzheimer’s disease. Dr. Georg is the co-inventor of LusedraTM, which is marketed by Eisa Pharmaceuticals. She is a co-inventor of Minnelide, an anticancer agent in clinical trials, and of Gamedazol, a male contraceptive agent in preclinical development.
- Professor, Department of Experimental and Clinical Pharmacology, College of Pharmacy
James Cloyd, PharmD, is a Morse Alumni Distinguished Teaching Professor, the Lawrence C. Weaver Endowed Chair in Orphan Drug Development, and Director of the Center for Orphan Drug Research at the University of Minnesota College of Pharmacy. Dr. Cloyd co-authored the orphan drug application for diazepam rectal gel (Diastat) and was a leader in the development of the product. His research interests include: orphan drugs, clinical neuropharmacology, antiepileptic drugs, rare pediatric neurological disorders.
- Professor, College of Pharmacy
- Associate Department Head, Pharmaceutical Care & Health Systems
Dr. Jon Schommer is a professor in the College of Pharmacy and the Associate Department Head of Pharmaceutical Care and Health Systems. Dr. Schommer focuses his work using health behavior theories such as; cognitive social and behavior psychology, marketing models and consumer behavior. His research interests are supported by; the development, delivery, and promotion of pharmacist services; an understanding of patients' knowledge, use, and evaluation of pharmacist services; a patient-centered perspective of appropriate drug use; and decision making about the feasibility of drug therapies and pharmacist services for improving patient care outcomes and containing health care costs.
- Professor, Pharmaceutical Economics, College of Pharmacy
- Head, Department of Pharmaceutical Care and Health Systems
- Director, PRIME Institute
- Century Mortar Club Endowed Chair in Pharmaceutical Management and Economics
Stephen W. Schondelmeyer, PharmD, PhD, a professor of Pharmaceutical Economics in the College of Pharmacy, is an expert in the practice of pharmaceutical care and its role in the healthcare system. He is knowledgable in topics including prescription drug reimbursement, drug benefit plans, pricing patterns of the pharmaceutical industry. His research projects have included prescription drug reimbursement under Medicaid, Medicare and other programs; pharmaceutical prices and patents; and pharmaceutical competition. He has conducted research for sponsors including the Centers for Medicare and Medicaid Services, the U.S. Special Committee on Aging and the Food and Drug Administration.
- Professor, Pharmaceutical Care & Health Systems
- Director, Ambulatory Care Residency Program, College of Pharmacy
As a pharmacist, professor and director of the U of M College of Pharmacy’s pharmacist residency program, Sarah Westberg is well versed in pharmacist-patient interactions. During medication management appointments, she meets with patients one-on-one to review current medications, adjusts dosages and identifies conflicting or unhelpful medicines. Her pharmacy expertise uniquely qualifies her to improve patient health through medication optimization. Westberg is available to discuss this patient-centered pharmaceutical care, especially in the context of diabetes or women’s health.